Literature DB >> 22700751

Factors influencing clinically meaningful recanalization after IV-rtPA in acute ischemic stroke.

A Murphy1, S P Symons, J Hopyan, R I Aviv.   

Abstract

BACKGROUND AND
PURPOSE: Recanalization may not result in better clinical outcomes after ischemic stroke. We determined the incidence and significant predictors of CMR, defined as CT angiographic recanalization and a good clinical outcome, after IV-rtPA in acute ischemic stroke. A CMR score was devised and tested.
MATERIALS AND METHODS: One hundred twenty-six consecutive patients with anterior circulation ischemic stroke receiving IV-rtPA were retrospectively reviewed. Imaging included a baseline NCCT and CTA. Recanalization was assessed on a 24-hour CTA. Clinical outcome was determined by the 90-day mRS. CMR was defined as CTA recanalization and a good clinical outcome (mRS ≤2). Logistic regression analysis determined predictors of CMR. The predictive ability of a CMR score was tested with AIC.
RESULTS: CMR occurred in 29% (36/126). Patients with CMR had fewer neurologic deficits (P = .001) and higher ASPECTS (P = .041) at baseline than those without CMR. Baseline NIHSS score did not predict proximal occlusion (OR 0.959; 95% CI [0.907-1.014]; P = .141). Multivariate analysis showed admission NIHSS score (P = .001) and the site of vessel occlusion (P = .022) to be significant CMR predictors. CMR was significantly less likely in patients with proximal occlusions (ICA, P = .005; proximal M1, P = .021). A CMR score better predicted CMR than either NIHSS or vessel occlusion site alone (P < .0001).
CONCLUSIONS: Milder baseline stroke deficit and distal vessel occlusion are significant predictors of CMR. A combination of these parameters better predicts CMR than either parameter alone.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22700751      PMCID: PMC7966325          DOI: 10.3174/ajnr.A3169

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  41 in total

1.  AIC model selection using Akaike weights.

Authors:  Eric-Jan Wagenmakers; Simon Farrell
Journal:  Psychon Bull Rev       Date:  2004-02

2.  Predictors of tissue-type plasminogen activator nonresponders according to location of vessel occlusion.

Authors:  Nuno Mendonça; David Rodriguez-Luna; Marta Rubiera; Sandra Boned-Riera; Marc Ribo; Jorge Pagola; Socorro Piñeiro; Pilar Meler; Jose Alvarez-Sabin; Joan Montaner; Carlos A Molina
Journal:  Stroke       Date:  2011-12-01       Impact factor: 7.914

3.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

Authors:  G J del Zoppo; R T Higashida; A J Furlan; M S Pessin; H A Rowley; M Gent
Journal:  Stroke       Date:  1998-01       Impact factor: 7.914

4.  Recanalization within one hour after intravenous tissue plasminogen activator is associated with favorable outcome in acute stroke patients.

Authors:  Kazumi Kimura; Yasuyuki Iguchi; Kensaku Shibazaki; Junya Aoki; Masao Watanabe; Kazuto Kobayashi; Yuki Sakamoto
Journal:  Eur Neurol       Date:  2010-06-03       Impact factor: 1.710

5.  National Institutes of Health Stroke Scale score is poorly predictive of proximal occlusion in acute cerebral ischemia.

Authors:  Matthew B Maas; Karen L Furie; Michael H Lev; Hakan Ay; Aneesh B Singhal; David M Greer; Gordon J Harris; Elkan Halpern; Walter J Koroshetz; Wade S Smith
Journal:  Stroke       Date:  2009-07-16       Impact factor: 7.914

6.  Good clinical outcome after ischemic stroke with successful revascularization is time-dependent.

Authors:  P Khatri; T Abruzzo; S D Yeatts; C Nichols; J P Broderick; T A Tomsick
Journal:  Neurology       Date:  2009-09-29       Impact factor: 9.910

7.  Risk of symptomatic intracerebral hemorrhage in patients treated with intra-arterial thrombolysis.

Authors:  O C Singer; J Berkefeld; M W Lorenz; J Fiehler; G W Albers; M G Lansberg; A Kastrup; A Rovira; D S Liebeskind; A Gass; C Rosso; L Derex; J S Kim; T Neumann-Haefelin
Journal:  Cerebrovasc Dis       Date:  2009-02-16       Impact factor: 2.762

8.  Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study.

Authors:  Michael P Marks; Jean-Marc Olivot; Stephanie Kemp; Maarten G Lansberg; Roland Bammer; Lawrence R Wechsler; Gregory W Albers; Vincent Thijs
Journal:  Radiology       Date:  2008-11       Impact factor: 11.105

9.  Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial.

Authors:  Wade S Smith; Gene Sung; Jeffrey Saver; Ronald Budzik; Gary Duckwiler; David S Liebeskind; Helmi L Lutsep; Marilyn M Rymer; Randall T Higashida; Sidney Starkman; Y Pierre Gobin; Donald Frei; Thomas Grobelny; Frank Hellinger; Dan Huddle; Chelsea Kidwell; Walter Koroshetz; Michael Marks; Gary Nesbit; Isaac E Silverman
Journal:  Stroke       Date:  2008-02-28       Impact factor: 7.914

10.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

Authors:  W Hacke; M Kaste; C Fieschi; D Toni; E Lesaffre; R von Kummer; G Boysen; E Bluhmki; G Höxter; M H Mahagne
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

View more
  8 in total

Review 1.  Endovascular therapy in hyperacute ischaemic stroke: history and current status.

Authors:  Alex M Mortimer; Marcus D Bradley; Shelley A Renowden
Journal:  Interv Neuroradiol       Date:  2013-12-18       Impact factor: 1.610

2.  Predictors of reperfusion in patients with acute ischemic stroke.

Authors:  A D Horsch; J W Dankbaar; J M Niesten; T van Seeters; I C van der Schaaf; Y van der Graaf; W P Th M Mali; B K Velthuis
Journal:  AJNR Am J Neuroradiol       Date:  2015-04-23       Impact factor: 3.825

3.  Effect of Collaterals on Clinical Presentation, Baseline Imaging, Complications, and Outcome in Acute Stroke.

Authors:  E M Fanou; J Knight; R I Aviv; S-P Hojjat; S P Symons; L Zhang; M Wintermark
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-15       Impact factor: 3.825

4.  Contribution and additional impact of imaging to the SPAN-100 score.

Authors:  P Krishnan; G Saposnik; B Ovbiagele; L Zhang; S Symons; R Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-08       Impact factor: 3.825

5.  Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials: Consensus Recommendations and Further Research Priorities.

Authors:  Steven J Warach; Marie Luby; Gregory W Albers; Roland Bammer; Andrew Bivard; Bruce C V Campbell; Colin Derdeyn; Jeremy J Heit; Pooja Khatri; Maarten G Lansberg; David S Liebeskind; Charles B L M Majoie; Michael P Marks; Bijoy K Menon; Keith W Muir; Mark W Parsons; Achala Vagal; Albert J Yoo; Andrei V Alexandrov; Jean-Claude Baron; David J Fiorella; Anthony J Furlan; Josep Puig; Peter D Schellinger; Max Wintermark
Journal:  Stroke       Date:  2016-04-12       Impact factor: 7.914

6.  Intravenous thrombolysis before endovascular therapy for large vessel strokes can lead to significantly higher hospital costs without improving outcomes.

Authors:  Ansaar T Rai; SoHyun Boo; Chelsea Buseman; Amelia K Adcock; Abdul R Tarabishy; Maurice M Miller; Thomas D Roberts; Jennifer R Domico; Jeffrey S Carpenter
Journal:  J Neurointerv Surg       Date:  2017-01-06       Impact factor: 5.836

7.  Early recanalization in large-vessel occlusion stroke patients transferred for endovascular treatment.

Authors:  Nerea Arrarte Terreros; Agnetha A E Bruggeman; Isabella S J Swijnenburg; Laura C C van Meenen; Adrien E Groot; Jonathan M Coutinho; Yvo B W E M Roos; Bart J Emmer; Ludo F M Beenen; Ed van Bavel; Henk A Marquering; Charles B L M Majoie
Journal:  J Neurointerv Surg       Date:  2021-05-13       Impact factor: 8.572

8.  Perampanel Reduces Brain Damage via Induction of M2 Microglia in a Neonatal Rat Stroke Model.

Authors:  Hyo Jung Shin; Ka Young Lee; Dong Woon Kim; Yoon Young Yi; Joon Won Kang; Seung Gyu Choi
Journal:  Int J Nanomedicine       Date:  2022-06-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.